TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 3
- −2 vs. Q4 2022
- Portfolio value
- $83.0M
- −$44.6M (−35.0%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PLRXPliant Therapeutics, Inc. | COM | 1,839,160 | $48.9M | 59.0% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 3,185,291 | $24.6M | 29.6% | −2,243,642−41.3% | Reduced | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $9.48M | 11.4% | 00.0% | Unchanged | History |
Sold out since Q4 2022 (2)
Positions held at the end of Q4 2022 that are gone from this filing.